GlassScriptPhysician profile
Gregory Alan Stanley
NPI 1225238272
$303,832.65
in general payments reported to CMS, 2019-2025
22 companies · $61K in 2025
The $61K reported for 2025 was more than what 99% of Surgery providers received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $93K · 2020: $17K · 2021: $25K · 2022: $45K · 2023: $33K · 2024: $30K · 2025: $61K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $80K · Travel and Lodging: $23K · Food and Beverage: $12K · Consulting Fee: $8,250.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $79,662.50 |
| Travel and Lodging | $22,509.11 |
| Food and Beverage | $12,406.25 |
| Consulting Fee | $8,250.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $145,112.17 | 2021-2025 | Hawkone, Turbohawk, Heli-Fx Endoanchor System |
| Medtronic Vascular, INC. | $106,114.30 | 2019-2020 | |
| Boston Scientific Corporation | $44,007.72 | 2019-2025 | General - Therapies, Ekosonic, General - Vascular Intervention |
| W. L. Gore & Associates, INC. | $3,304.78 | 2019-2025 | Gore Tag Thoracic Endoprosthesis, Excluder Conformable Aaa Endoprosthesis With Active Control, Gore Viabahn Endoprosthesis |
| Silk Road Medical, INC. | $1,375.15 | 2019-2024 | Enroute Transcarotid Neuroprotection System, Enroute Transcarotid Stent, Enroute Enflate Transcarotid Rx Balloon Dilatation Catheter |
| Kci USA, INC. | $850.00 | 2020 | |
| Cvrx, INC. | $522.90 | 2024-2025 | Barostim Neo System |
| Limflow INC. | $379.19 | 2023 | Limflow System |
| Heartflow, INC. | $324.44 | 2021-2023 | Ffrct |
| Philips North America LLC | $293.27 | 2019-2024 | (Br5) Peripheral Ivus |
| Shockwave Medical, INC | $275.22 | 2025 | |
| Kerecis Limited | $210.56 | 2021-2024 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Marigen, Kerecis Omega3 Graftguide |
| Abbott Laboratories | $209.82 | 2024-2025 | Esprit |
| Teleflex LLC | $144.12 | 2024 | Manta |
| Inari Medical, INC. | $142.77 | 2025 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cook Medical LLC | $130.10 | 2019-2025 | Zenith Alpha, Zilver Ptx |
| Penumbra, INC. | $125.00 | 2019 | |
| Bard Peripheral Vascular, INC. | $123.92 | 2019 | |
| Inspiremd LTD | $120.06 | 2025 | Cguard Prime Carotid Stent System |
| Janssen Pharmaceuticals, INC | $38.00 | 2022 | |
| Lemaitre Vascular, INC. | $24.08 | 2025 | Hydro Lemaitre Valvulotome |
| Musculoskeletal Transplant Foundation INC. | $5.08 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gregory Stanley listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.